Active ingredientGrepafloxacinCat. No. P-G061-001CAS 119914-60-2Family · Pharmaceutical analytical standards
Grepafloxacin
An oral broad-spectrum fluoroquinolone antibiotic, synthesised in Japan and approved in 1997 for acute exacerbations of chronic bronchitis, pneumonia and some sexually transmitted infections; it was withdrawn from the market in 1999. This family brings together the active ingredient and other impurities.
Did you know?To make it, chemists temporarily "blocked" position 8 of the quinolone ring with a silyl group, so that a methyl group could be added at position 5.
Go to the active ingredient →Active ingredientGrepafloxacinCat. No. P-G061-001CAS 119914-60-2
ImpurityGrepafloxacin Impurity 1Cat. No. P-G061-002CAS 119914-61-3
ImpurityGrepafloxacin Impurity 2Cat. No. P-G061-003
ImpurityGrepafloxacin Impurity 3Cat. No. P-G061-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.